Safety

Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)

March 2015

Summary View

USE IN SPECIFIC POPULATIONS

  • Pediatric Use section updated

 

September 2013

Summary View

ADVERSE REACTIONS

Postmarketing Adverse Reactions
  • added ... dysphonia and gastroesophageal reflux disease
     

 

Page Last Updated: 04/15/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.